252 related articles for article (PubMed ID: 19243146)
1. Structural basis for inhibition of mammalian adenylyl cyclase by calcium.
Mou TC; Masada N; Cooper DM; Sprang SR
Biochemistry; 2009 Apr; 48(15):3387-97. PubMed ID: 19243146
[TBL] [Abstract][Full Text] [Related]
2. Structural basis for the inhibition of mammalian membrane adenylyl cyclase by 2 '(3')-O-(N-Methylanthraniloyl)-guanosine 5 '-triphosphate.
Mou TC; Gille A; Fancy DA; Seifert R; Sprang SR
J Biol Chem; 2005 Feb; 280(8):7253-61. PubMed ID: 15591060
[TBL] [Abstract][Full Text] [Related]
3. Molecular basis for P-site inhibition of adenylyl cyclase.
Tesmer JJ; Dessauer CW; Sunahara RK; Murray LD; Johnson RA; Gilman AG; Sprang SR
Biochemistry; 2000 Nov; 39(47):14464-71. PubMed ID: 11087399
[TBL] [Abstract][Full Text] [Related]
4. Inhibition by calcium of mammalian adenylyl cyclases.
Guillou JL; Nakata H; Cooper DM
J Biol Chem; 1999 Dec; 274(50):35539-45. PubMed ID: 10585428
[TBL] [Abstract][Full Text] [Related]
5. Structural basis for the high-affinity inhibition of mammalian membranous adenylyl cyclase by 2',3'-o-(N-methylanthraniloyl)-inosine 5'-triphosphate.
Hübner M; Dixit A; Mou TC; Lushington GH; Pinto C; Gille A; Geduhn J; König B; Sprang SR; Seifert R
Mol Pharmacol; 2011 Jul; 80(1):87-96. PubMed ID: 21498658
[TBL] [Abstract][Full Text] [Related]
6. A critical interplay between Ca2+ inhibition and activation by Mg2+ of AC5 revealed by mutants and chimeric constructs.
Hu B; Nakata H; Gu C; De Beer T; Cooper DM
J Biol Chem; 2002 Sep; 277(36):33139-47. PubMed ID: 12065575
[TBL] [Abstract][Full Text] [Related]
7. Differential inhibition of adenylyl cyclase isoforms and soluble guanylyl cyclase by purine and pyrimidine nucleotides.
Gille A; Lushington GH; Mou TC; Doughty MB; Johnson RA; Seifert R
J Biol Chem; 2004 May; 279(19):19955-69. PubMed ID: 14981084
[TBL] [Abstract][Full Text] [Related]
8. Differential inhibition of various adenylyl cyclase isoforms and soluble guanylyl cyclase by 2',3'-O-(2,4,6-trinitrophenyl)-substituted nucleoside 5'-triphosphates.
Suryanarayana S; Göttle M; Hübner M; Gille A; Mou TC; Sprang SR; Richter M; Seifert R
J Pharmacol Exp Ther; 2009 Sep; 330(3):687-95. PubMed ID: 19494187
[TBL] [Abstract][Full Text] [Related]
9. Two-metal-Ion catalysis in adenylyl cyclase.
Tesmer JJ; Sunahara RK; Johnson RA; Gosselin G; Gilman AG; Sprang SR
Science; 1999 Jul; 285(5428):756-60. PubMed ID: 10427002
[TBL] [Abstract][Full Text] [Related]
10. Interaction of Gsalpha with the cytosolic domains of mammalian adenylyl cyclase.
Sunahara RK; Dessauer CW; Whisnant RE; Kleuss C; Gilman AG
J Biol Chem; 1997 Aug; 272(35):22265-71. PubMed ID: 9268375
[TBL] [Abstract][Full Text] [Related]
11. The C2 catalytic domain of adenylyl cyclase contains the second metal ion (Mn2+) binding site.
Mitterauer T; Hohenegger M; Tang WJ; Nanoff C; Freissmuth M
Biochemistry; 1998 Nov; 37(46):16183-91. PubMed ID: 9819210
[TBL] [Abstract][Full Text] [Related]
12. Structural and kinetic analyses of the interaction of anthrax adenylyl cyclase toxin with reaction products cAMP and pyrophosphate.
Guo Q; Shen Y; Zhukovskaya NL; Florián J; Tang WJ
J Biol Chem; 2004 Jul; 279(28):29427-35. PubMed ID: 15131111
[TBL] [Abstract][Full Text] [Related]
13. The structures of Escherichia coli inorganic pyrophosphatase complexed with Ca(2+) or CaPP(i) at atomic resolution and their mechanistic implications.
Samygina VR; Popov AN; Rodina EV; Vorobyeva NN; Lamzin VS; Polyakov KM; Kurilova SA; Nazarova TI; Avaeva SM
J Mol Biol; 2001 Nov; 314(3):633-45. PubMed ID: 11846572
[TBL] [Abstract][Full Text] [Related]
14. Mammalian Nucleotidyl Cyclases and Their Nucleotide Binding Sites.
Dove S
Handb Exp Pharmacol; 2017; 238():49-66. PubMed ID: 27900607
[TBL] [Abstract][Full Text] [Related]
15. Isoform selectivity of adenylyl cyclase inhibitors: characterization of known and novel compounds.
Brand CS; Hocker HJ; Gorfe AA; Cavasotto CN; Dessauer CW
J Pharmacol Exp Ther; 2013 Nov; 347(2):265-75. PubMed ID: 24006339
[TBL] [Abstract][Full Text] [Related]
16. Adenylyl cyclase 5 links changes in calcium homeostasis to cAMP-dependent cyst growth in polycystic liver disease.
Spirli C; Mariotti V; Villani A; Fabris L; Fiorotto R; Strazzabosco M
J Hepatol; 2017 Mar; 66(3):571-580. PubMed ID: 27826057
[TBL] [Abstract][Full Text] [Related]
17. Inhibition of adenylyl and guanylyl cyclase isoforms by the antiviral drug foscarnet.
Kudlacek O; Mitterauer T; Nanoff C; Hohenegger M; Tang WJ; Freissmuth M; Kleuss C
J Biol Chem; 2001 Feb; 276(5):3010-6. PubMed ID: 11050094
[TBL] [Abstract][Full Text] [Related]
18. A novel mechanism for adenylyl cyclase inhibition from the crystal structure of its complex with catechol estrogen.
Steegborn C; Litvin TN; Hess KC; Capper AB; Taussig R; Buck J; Levin LR; Wu H
J Biol Chem; 2005 Sep; 280(36):31754-9. PubMed ID: 16002394
[TBL] [Abstract][Full Text] [Related]
19. Association of Both Inhibitory and Stimulatory Gα Subunits Implies Adenylyl Cyclase 5 Deactivation.
van Keulen SC; Narzi D; Rothlisberger U
Biochemistry; 2019 Oct; 58(42):4317-4324. PubMed ID: 31525953
[TBL] [Abstract][Full Text] [Related]
20. Crystal structure of the catalytic domains of adenylyl cyclase in a complex with Gsalpha.GTPgammaS.
Tesmer JJ; Sunahara RK; Gilman AG; Sprang SR
Science; 1997 Dec; 278(5345):1907-16. PubMed ID: 9417641
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
